Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR)
- PMID: 9039176
- DOI: 10.1016/s0190-9622(97)70288-3
Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR)
Abstract
Background: Although intralesional vinblastine has been used with some success in the treatment of cutaneous lesions of Kaposi's sarcoma (KS), lesions commonly recur. When large lesions are treated, frequently there is considerable discomfort and, in some cases, secondary ulceration. Hyaluronidase has been used to increase dispersion of drugs administered by local injection.
Objective: Our purpose was to determine whether intralesional hyaluronidase administered before intralesional vinblastine increases the dispersion of vinblastine and decreases toxicity.
Methods: We treated six patients who had multiple cutaneous plaque lesions and tumors of KS with intralesional vinblastine, intralesional vinblastine preceded by intralesional hyaluronidase, or intralesional hyaluronidase alone.
Results: Both intralesional vinblastine and intralesional vinblastine preceded by intralesional hyaluronidase caused clinical regression of lesions of KS; however, the combination of hyaluronidase and vinblastine was more effective in treating tumor nodules. In addition, lesions treated with hyaluronidase and vinblastine recurred less often than those treated with vinblastine alone and showed no evidence of residual KS in two patients undergoing biopsy between 4 and 6 months after therapy.
Conclusion: Intralesional hyaluronidase enhances vinblastine in the treatment of cutaneous lesions of KS without adding to the systemic toxicity.
Similar articles
-
Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.Eur J Cancer B Oral Oncol. 1995 Jul;31B(4):280-5. doi: 10.1016/0964-1955(95)00009-7. Eur J Cancer B Oral Oncol. 1995. PMID: 7492927 Clinical Trial.
-
[Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].Ann Otolaryngol Chir Cervicofac. 1999 Oct;116(5):291-4. Ann Otolaryngol Chir Cervicofac. 1999. PMID: 10572593 French.
-
Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.J Oral Maxillofac Surg. 1996 May;54(5):583-7; discussion 588-9. doi: 10.1016/s0278-2391(96)90637-0. J Oral Maxillofac Surg. 1996. PMID: 8632242
-
Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.Oral Oncol. 2002 Jul;38(5):460-7. doi: 10.1016/s1368-8375(01)00100-2. Oral Oncol. 2002. PMID: 12110340 Review.
-
Kaposi's sarcoma: an update.J Surg Oncol. 2004 Sep 1;87(3):146-51. doi: 10.1002/jso.20090. J Surg Oncol. 2004. PMID: 15334644 Review.
Cited by
-
Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery.Curr Opin Chem Eng. 2015 Feb 1;7:65-74. doi: 10.1016/j.coche.2014.11.003. Curr Opin Chem Eng. 2015. PMID: 25745594 Free PMC article.
-
Hyalurondiase: both a tumor promoter and suppressor.Semin Cancer Biol. 2008 Aug;18(4):281-7. doi: 10.1016/j.semcancer.2008.03.008. Epub 2008 Mar 26. Semin Cancer Biol. 2008. PMID: 18448355 Free PMC article. Review.
-
Effect of Matrix-Modulating Enzymes on The Cellular Uptake of Magnetic Nanoparticles and on Magnetic Hyperthermia Treatment of Pancreatic Cancer Models In Vivo.Nanomaterials (Basel). 2021 Feb 9;11(2):438. doi: 10.3390/nano11020438. Nanomaterials (Basel). 2021. PMID: 33572222 Free PMC article.
-
Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.Nanomedicine (Lond). 2011 Nov;6(9):1605-20. doi: 10.2217/nnm.11.141. Nanomedicine (Lond). 2011. PMID: 22077464 Free PMC article. Review.
-
Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.Gastroenterology. 2016 Jun;150(7):1545-1557.e2. doi: 10.1053/j.gastro.2016.03.040. Epub 2016 Apr 9. Gastroenterology. 2016. PMID: 27072672 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
